Related Experiment Videos
Antibiotic susceptibility of Acinetobacter species in intensive care unit in Montenegro
Gordana Mijovic1, Ljubica Pejakov2, Danijela Vujosevic1
1a Institute of Public Health , Podgorica , Montenegro.
Abstract:
The global increase in multidrug resistance of Acinetobacter has created widespread problems in the treatment of patients in intensive care units (ICUs). The aim of this study was to assess the current level of antimicrobial susceptibility of Acinetobacter species in ICU of Clinical Centre of Montenegro and determine their epidemiology. Antibiotic susceptibility was tested in 70 isolates of Acinetobacter collected from non-repeating samples taken from 40 patients. The first nine isolates were genotyped by repetitive sequence-based PCR (rep-PCR). Tigecycline was found to be the most active antimicrobial agent with 80.6% of susceptibility. All the isolates were multidrug resistant with fully resistance to cefalosporinas, piperacillin and piperacillin/tazobactam. More than half of them (58.5%) were probably extensively resistant. Seven out of nine examined strains were clonally related by rep-PCR. Our results showed extremely high rate of multidrug resistance (MDR) of Acinetobacter isolates and high percentage of its clonally spreading.
Insights
Multidrug-resistant Acinetobacter strains pose significant treatment challenges in intensive care units (ICUs). This study found high rates of resistance and clonal spread among Acinetobacter isolates in Montenegro, with tigecycline showing the most activity.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Increasing multidrug resistance (MDR) in Acinetobacter species presents a critical global health challenge, particularly impacting patients in intensive care units (ICUs).
- Effective treatment strategies are hampered by the limited antimicrobial options available against resistant Acinetobacter strains.
Purpose of the Study:
- To evaluate the antimicrobial susceptibility patterns of Acinetobacter species within the ICU of the Clinical Centre of Montenegro.
- To investigate the epidemiology and clonal dissemination of Acinetobacter isolates in this healthcare setting.
Main Methods:
- Antibiotic susceptibility testing was performed on 70 Acinetobacter isolates from 40 patients.
- Genotyping of nine isolates was conducted using repetitive sequence-based PCR (rep-PCR) to assess clonal relatedness.
Main Results:
- All Acinetobacter isolates exhibited multidrug resistance, with complete resistance to cefalosporins, piperacillin, and piperacillin/tazobactam.
- Tigecycline demonstrated the highest antimicrobial activity, with 80.6% susceptibility. Over half of the isolates (58.5%) were classified as probably extensively drug-resistant (P-EDR).
- Repetitive sequence-based PCR (rep-PCR) revealed that seven of the nine examined strains were clonally related, indicating potential clonal spread.
Conclusions:
- Acinetobacter isolates in the Clinical Centre of Montenegro display an alarmingly high rate of multidrug resistance and P-EDR.
- The findings highlight the significant clonal spread of Acinetobacter within the ICU, underscoring the need for enhanced infection control measures.
- Tigecycline remains a crucial therapeutic option, but the high resistance rates necessitate continuous surveillance and the development of novel antimicrobial strategies.
Related Concept Videos
Antimicrobial Effectiveness
Clinical Significance of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management
Mechanism of Antibiotic Resistance in MRSA
Antibiotic Selection
Urine Studies II: Urine Culture and Sensitivity Test